Print this post.
Posted on 6/15/2020
During the COVID-19 public health emergency, legislative mandates and administrative authorities have allowed the Centers for Medicare & Medicaid Services (CMS) to issue temporary Medicare waivers and rules. Combined, these policies have let beneficiaries receive a wider range of health services from home, from a broader array of providers, and using more types of technology. (Read more...)
How the Cost of Pharmaceutical Drugs Can & May Be Made More Affordable for All U.S. Citizens 💡
On July 24, President Trump signed four executive orders on prescription drugs, which are focused on implementing drug pricing reform. Put simply, the executive orders focus on the amount Medicare pays drug companies for drugs administered in physician offices; most favored nation pricing and reducing the cost of insulin and epinephrine. (Read more...)
Comments are closed